Door-to-defecation time…
Defecation Patterns and Cardiovascular Outcomes in Acute Coronary Syndrome: The Influence of Stimulant Laxative Use
https://t.co/wypacDc2aH
Summary of all Late-Breaking Trials at #ACC2026 – take home points
@ACCinTouch@ACCmediacenter@JACCJournals
1. HI-PEITHO: Ultrasound-facilitated catheter-directed thrombolysis led to a lower risk of PE-related death, cardiopulmonary decompensation or collapse, or recurrence of PE. vs anticoagulation alone in intermediate-high risk PE.
A few weeks ago, I graduated from @RushUniversity. Completing my Master’s degree during residency/fellowship initially felt impossible, hard to believe it’s done. Incredibly grateful for the journey, the support, and the opportunity to celebrate at such a wonderful ceremony.
Great presentations from our fellows at WMC Research Day. Congrats to @CMeht1947 for winning Best Fellow Research Presentation 🎉
Big shoutout to medicine department for the organization and engagement @DrRhthm
1/14
Why can't you use direct oral anticoagulants (DOACs) in patients with mechanical valves (MVs)?
DOACs have been one of the most important advances in my career. And yet, the presence of a MV is one of the few contraindications.
The reason highlights the unique nature of thrombus formation in those with a MV and provides insights into the evolution of human hemostasis.
Check out this @JAHA_AHA paper co-authored by our fellow @AmroAglanMD & HCM director @SrihariNaiduMD with great external collaboration.
Exciting to see how quickly the HCM space is evolving, with important questions still to be answered.
https://t.co/0yu4QBIVbC
An elderly hospitalized patient with irregular heart beat. The team is considering Afib. Mitral inflow PW Doppler is shown. What is the likely explanation?
Big congratulations to @ImranAziz96, our star first-year fellow, on completing his Master’s degree and presenting his thesis today on using AI in the management of CAD patients. 🎓👏🏼 #ACCFIT
OPTIMAL suggests that using IVUS in unprotected left main PCI may cost you 22 minutes with no clinical benefit. One might think it’s an outlier. Yet, the same day, IVUS-CHIP reports no advantage of IVUS over angiography in complex high-risk PCI. Either we have been fundamentally misinterpreting the evidence so far, or we urgently need to reconcile these data. #ACC26
https://t.co/eoJzCtVy8h
https://t.co/6kYUhV1Sbm